Serina Therapeutics (SER) Other Non-Current Liabilities (2018 - 2025)
Serina Therapeutics (SER) posted Other Non-Current Liabilities of $3.55 million for Q2 2025, down 73.5% from $13.41 million a year earlier but up 36.9% from the prior quarter.
Powered by 
Analysis
Serina Therapeutics (SER) Other Non-Current Liabilities (2018 - 2025) Analysis & Trends
At the end of FY2024, Serina Therapeutics' Other Non-Current Liabilities came in at $3.58 million.
- Annual Other Non-Current Liabilities shows a five-year compound annual growth rate of 18.6% (FY2019 to FY2024).
- In prior years, Serina Therapeutics' Other Non-Current Liabilities was $180,000 in FY2022 (-97.0%), $6.06 million in FY2021 (+55.4%) and $3.9 million in FY2020 (+155.2%).
- Quarterly Other Non-Current Liabilities has run from a low of $180,000 in Q4 2022 to a high of $24.08 million in Q1 2024 over five years.
- The strongest year-over-year quarter for Other Non-Current Liabilities in the past five years was Q2 2021, with growth of 221.2%; the weakest was Q4 2022, with a decline of 97.0%.
- According to Business Quant data, Other Non-Current Liabilities for the three prior quarters was $2.59 million (Q1 2025), $3.58 million (Q4 2024) and $6.74 million (Q3 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Serina Therapeutics | 23.59 Mn | -35.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 88,000.00 |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Sep 30, 2024 | 6.74 Mn |
| Jun 30, 2024 | 13.41 Mn |
| Mar 31, 2024 | 24.08 Mn |
| Mar 31, 2023 | 347,000.00 |
| Dec 31, 2022 | 180,000.00 |
| Sep 30, 2022 | 657,000.00 |
| Jun 30, 2022 | 7.79 Mn |
| Mar 31, 2022 | 5.82 Mn |
| Dec 31, 2021 | 6.06 Mn |
| Sep 30, 2021 | 5.81 Mn |
| Jun 30, 2021 | 5.56 Mn |
| Mar 31, 2021 | 5.33 Mn |
| Dec 31, 2020 | 3.90 Mn |
| Sep 30, 2020 | 3.10 Mn |
| Jun 30, 2020 | 1.73 Mn |
API Access
Serina Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();